GlaxoSmithKline Forms New Unit For Least Developed Countries

1st Jul 2010 16:17

LONDON (Dow Jones)--GlaxoSmithKline PLC (GSK.LN), a global healthcare group, announced Thursday it has created a new operating unit dedicated to expanding access to medicines for people living in the Least Developed Countries or LDCs. MAIN FACTS: -A new Developing Countries and Market Access operating unit has been created which will integrate GSK's pharmaceutical business in LDCs into one group. -The group will provide a dedicated focus on the strategic approaches needed to expand access to medicines for patients living in these countries. -Duncan Learmouth is appointed to lead this new group, effective August 1 . -Learmouth will report to Abbas Hussain, President, Emerging Markets/Asia Pacific. -The new group will also include the Market Access function that supports access programs and policies for the wider Emerging Markets and Asia Pacific (EMAP) Region. -Shares at 1515 GMT down 35 pence, or 3.06%, at 1108 pence. -By Zechariah Hemans, Dow Jones Newswires; 44-20-7842-9411; [email protected] (END) Dow Jones Newswires July 01, 2010 11:17 ET (15:17 GMT)